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Background: Tuberculosis is the leading cause of mortality
worldwide and kill 3 million people every year. It is caused by
members of the Mycobacterium tuberculosis complex (MTC). Zambia
is ranked among the world’s top 10 high incident countries. Lack
of routine mulecular characterization of mycobacteria in patients
presenting with pulmonary tuberculosis in the country’s health
facilities including Ndola Central Hospital has led to non availablity
of data on speciﬁc species other than M. tuberculosis that are in cir-
culation. This information is vital for proper patient management,
as different species and strains of mycobacteria have varying sen-
sitivies to drugs, pathogenesis as well as their epidemiology. The
study was aimed at characterizing members of the MTC in patients
presenting with pulmonary tuberculosis at Ndola Central Hospital
in Zambia from February 2012 to August 2012.
Methods & Materials: This was a cross-sectional study target-
ing symptomatic and clinically suspected pulmonary TB patients
attending Ndola Central Hospital. A total of 197 consenting adult
patiets were included in the study, from whom a structured ques-
tionnaire probing their socio- economic, HIV status and possible
source of the disease status. Additionally, 2 sputum samples were
collected from where Microscopy, culture, spoligotyping and dele-
tion analysis were carried out.
Results:About 60%of theparticipantsweremale. The total posi-
tivity rate on culturewas 65% (N=138). Out of seventy-one samples
analysed for IS6110 deletion analysis, 41 sampleswhere conﬁrmed
to beM. tuberculosis since theywere positive for RD1, RD4, RD9 and
RD12. Four samples were conﬁrmed to be M. canettii as character-
ized by the absence of RD12 ampliﬁcation. Among the six clusters
obtained by spoligotyping, the SAF1 family was largest compris-
ing 43.5% of the isolates. The study also found four orphan strains
which did not match with previously identiﬁed strains.
Conclusion:Other thanM. tuberculosis,Mcanettii has also been
implicated in Tuberculosis infection in Ndola.
http://dx.doi.org/10.1016/j.ijid.2014.03.1046
Type: Poster Presentation
Final Abstract Number: 56.008
Session: Tuberculosis and Other Mycobacterial Infections
Date: Friday, April 4, 2014
Time: 12:45-14:15
Room: Ballroom
Evaluation of AFB smear, culture, real-time PCR
methods for detection of tuberculosis
A. Sari1, G. Ongut1, B. Ozhak1, D. Daglar2, D.
Ogunc1, D. Colak1, A.N. Yalcin1
1 Akdeniz University, Medicine Faculty, Antalya,
Turkey
2 Antalya Education and Research Hospital, Antalya,
Turkey
Background: Direct microscopy and culture of microorganism
are conventionalmethods for detection ofmycobacteria infections.
Rapid and accurate laboratory diagnosis is important for global
control of tuberculosis. Nucleic acid ampliﬁcation tests which are
recommended by World Health (WHO) become popular methods
for rapid detection of Mycobacterium tuberculosis complex.
Methods & Materials: In this study, we assessed the perfor-
mance of twodifferent real-time PCRmethods (CepheidGeneXpert
and Roche Cobas TaqMan MTB) in diagnosis of tuberculosis. 50 AFB
(+) and 50 AFB (-) sputum samples were studied.
Results: The sensitivity, speciﬁcity, positive predictive value
and negative predictive value of Cepheid GeneXpert test were
75%,100%, 100% and 41.7, respectively.
The sensitivity, speciﬁcity, positive predictive value and nega-
tive predictive value of Roche Cobas TaqMan MTB test were 64.6%,
93.3%, 98.1% and 32.6, respectively.
Conclusion: We conclude that, Cepheid GeneXpert test and
Roche Cobas TaqMan MTB tests can allow rapid results useful both
for rapid treatment and patient management.
http://dx.doi.org/10.1016/j.ijid.2014.03.1047
